238 related articles for article (PubMed ID: 24583195)
1. A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.
Yin L; Stern LJ
J Immunol Methods; 2014 Apr; 406():21-33. PubMed ID: 24583195
[TBL] [Abstract][Full Text] [Related]
2. HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.
Yin L; Calvo-Calle JM; Dominguez-Amorocho O; Stern LJ
J Immunol; 2012 Oct; 189(8):3983-94. PubMed ID: 22966084
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.
Yin L; Stern LJ
Curr Protoc Immunol; 2014 Aug; 106():5.10.1-5.10.12. PubMed ID: 25081912
[TBL] [Abstract][Full Text] [Related]
4. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.
Yin L; Trenh P; Guce A; Wieczorek M; Lange S; Sticht J; Jiang W; Bylsma M; Mellins ED; Freund C; Stern LJ
J Biol Chem; 2014 Aug; 289(34):23449-64. PubMed ID: 25002586
[TBL] [Abstract][Full Text] [Related]
6. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4
Álvaro-Benito M; Morrison E; Ebner F; Abualrous ET; Urbicht M; Wieczorek M; Freund C
Cell Mol Immunol; 2020 Feb; 17(2):133-142. PubMed ID: 30467419
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of peptide repertoire selection by HLA-DM.
Pos W; Sethi DK; Wucherpfennig KW
Trends Immunol; 2013 Oct; 34(10):495-501. PubMed ID: 23835076
[TBL] [Abstract][Full Text] [Related]
8. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
[TBL] [Abstract][Full Text] [Related]
9. The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability.
Lazarski CA; Chaves FA; Sant AJ
J Exp Med; 2006 May; 203(5):1319-28. PubMed ID: 16682499
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability.
Anderson MW; Gorski J
J Immunol; 2003 Dec; 171(11):5683-7. PubMed ID: 14634075
[TBL] [Abstract][Full Text] [Related]
11. Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.
Álvaro-Benito M; Morrison E; Abualrous ET; Kuropka B; Freund C
Front Immunol; 2018; 9():872. PubMed ID: 29774024
[TBL] [Abstract][Full Text] [Related]
12. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
13. HLA-DM mediates epitope selection by a "compare-exchange" mechanism when a potential peptide pool is available.
Ferrante A; Anderson MW; Klug CS; Gorski J
PLoS One; 2008; 3(11):e3722. PubMed ID: 19005572
[TBL] [Abstract][Full Text] [Related]
14. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes.
Belmares MP; Busch R; Wucherpfennig KW; McConnell HM; Mellins ED
J Immunol; 2002 Nov; 169(9):5109-17. PubMed ID: 12391227
[TBL] [Abstract][Full Text] [Related]
15. HLA-DM and the MHC class II antigen presentation pathway.
Jensen PE; Weber DA; Thayer WP; Chen X; Dao CT
Immunol Res; 1999; 20(3):195-205. PubMed ID: 10741860
[TBL] [Abstract][Full Text] [Related]
16. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
17. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
19. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
Vogt AB; Kropshofer H; Hämmerling GJ
Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting cells and the selection of immunodominant epitopes.
Blum JS; Ma C; Kovats S
Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]